X-136207946-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_ModerateBP6_ModerateBP7BS2

The NM_001159702.3(FHL1):​c.486C>T​(p.Cys162Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000239 in 1,211,158 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000025 ( 0 hom. 5 hem. )

Consequence

FHL1
NM_001159702.3 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:2

Conservation

PhyloP100: 1.12

Publications

0 publications found
Variant links:
Genes affected
FHL1 (HGNC:3702): (four and a half LIM domains 1) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. Expression of these family members occurs in a cell- and tissue-specific mode and these proteins are involved in many cellular processes. Mutations in this gene have been found in patients with Emery-Dreifuss muscular dystrophy. Multiple alternately spliced transcript variants which encode different protein isoforms have been described.[provided by RefSeq, Nov 2009]
FHL1 Gene-Disease associations (from GenCC):
  • X-linked myopathy with postural muscle atrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • myopathy, reducing body, X-linked, early-onset, severe
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • reducing body myopathy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked Emery-Dreifuss muscular dystrophy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked scapuloperoneal muscular dystrophy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant X-136207946-C-T is Benign according to our data. Variant chrX-136207946-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 239010.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.12 with no splicing effect.
BS2
High Hemizygotes in GnomAdExome4 at 5 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FHL1NM_001159702.3 linkc.486C>T p.Cys162Cys synonymous_variant Exon 5 of 8 ENST00000394155.8 NP_001153174.1 Q13642-2
FHL1NM_001159699.2 linkc.534C>T p.Cys178Cys synonymous_variant Exon 4 of 6 ENST00000370683.6 NP_001153171.1 Q13642-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FHL1ENST00000394155.8 linkc.486C>T p.Cys162Cys synonymous_variant Exon 5 of 8 5 NM_001159702.3 ENSP00000377710.2 Q13642-2
FHL1ENST00000370683.6 linkc.534C>T p.Cys178Cys synonymous_variant Exon 4 of 6 1 NM_001159699.2 ENSP00000359717.1 Q13642-5

Frequencies

GnomAD3 genomes
AF:
0.0000177
AC:
2
AN:
113040
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000321
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000187
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000109
AC:
2
AN:
183238
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000245
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000246
AC:
27
AN:
1098118
Hom.:
0
Cov.:
31
AF XY:
0.0000138
AC XY:
5
AN XY:
363474
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26398
American (AMR)
AF:
0.00
AC:
0
AN:
35205
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19385
East Asian (EAS)
AF:
0.0000331
AC:
1
AN:
30205
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
54147
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40523
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4134
European-Non Finnish (NFE)
AF:
0.0000261
AC:
22
AN:
842030
Other (OTH)
AF:
0.0000651
AC:
3
AN:
46091
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000177
AC:
2
AN:
113040
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
35176
show subpopulations
African (AFR)
AF:
0.0000321
AC:
1
AN:
31144
American (AMR)
AF:
0.00
AC:
0
AN:
10799
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2659
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3591
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2766
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6253
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
0.0000187
AC:
1
AN:
53381
Other (OTH)
AF:
0.00
AC:
0
AN:
1521
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

X-linked myopathy with postural muscle atrophy Benign:1
Mar 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

FHL1-related disorder Benign:1
Aug 13, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
8.6
DANN
Benign
0.65
PhyloP100
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs377693754; hg19: chrX-135290105; COSMIC: COSV61782479; COSMIC: COSV61782479; API